Cellectis SA (CLLS NASDAQ) stock market data APIs
$1.0824
-0(-0%)
as of November 3, 2026
Try our APIs with
free plan!
Cellectis SA Financial Data Overview
Price chart is built with
Anychart
Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients with r/r ALL; NatHaLi-01, designed to evaluate the safety, expansion, persistence, and clinical activity of eti-cel in patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL). It also develops ALPHA3, targets Large B-Cell Lymphoma (LBCL); TRAVERSE, for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma (RCC). In addition, the company Melanoma, for treatment of unresectable or metastatic melanoma. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.
Prev. Close
1.0824
Open
1.0776
High
1.1378
Low
1.0688
52 wk Range
0.881-5.45
Market Cap
110 M
Shares Outstanding
72 733 K
Revenue
63 823 K
Beta
2.932
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cellectis SA (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cellectis SA data using free add-ons & libraries
Get Cellectis SA Fundamental Data
Cellectis SA Fundamental data includes:
- Net Revenue: 63 823 K
- EBITDA: -46 677 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-06
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cellectis SA News
New
European Equities Traded in the US as American Depositary Receipts Advance Sharply in Wednesday Trading
European equities traded in the US as American depositary receipts were tracking significantly highe Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news ...
European Equities Traded in the US as American Depositary Receipts Decline Slightly in Tuesday Trading
European equities traded in the US as American depositary receipts were tracking slightly lower late Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news ...
European Equities Traded in the US as American Depositary Receipts Steady in Wednesday Trading
European equities traded in the US as American depositary receipts were little changed around 1,893. PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026
Cellectis Inc. 70% in vivo editing of human APOC3 in a single administration 76% triglyceride reduction after a single dose in murine disease model NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cellec...
Get Cellectis SA fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.